Venture Capital

Galera Therapeutics Increases Series B Financing To $42M

by vcaonline.com posted 4years ago 5782 views
Galera Therapeutics, Inc., a clinical-stage biotech developing new treatments for cancer patients, announced today it has received an additional $5 million in funding from Enso Ventures to bring its Series B financing total to $42 million.